Opendata, web and dolomites

PROTECTA SIGNED

Pathogen-informed Resistance to Oomycete diseases in Ecosystems, Agriculture and Aquaculture

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PROTECTA project word cloud

Explore the words cloud of the PROTECTA project. It provides you a very rough idea of what is the project "PROTECTA" about.

reduce    blight    worldwide    functions    translate    security    eukaryotic    adaptable    resemble    quantification    plants    chemical    multidisciplinary    reveals    crop    aquaculture    smes    agencies    infestans    varieties    team    root    biological    pathogens    genetically    brown    abundance    microbes    tree    assembled    infecting    oak    breeding    classes    immune    destructive    algae    plant    re    companies    sudden    multinational    protein    oomycetes    lineage    ways    insects    recognised    ecosystems    pesticides    infect    expression    agricultural    genetics    government    dependence    agriculture    disease    global    determinants    genes    biochemistry    food    vegetable    diseases    oomycete    genomics    heterokont    fundamental    sectoral    saprolegniosis    host    gene    biochemical    damaging    fish    precise    hosts    resistance    threats    pathogen    inter    rots    data    notorious    proteins    durable    train    potato    effector    protecta    unprecedented    phytophthora    generation    manipulate    mechanisms    fungi    protect    interactions    pathogenicity    humans    natural    diverse    infection    vascular    occasionally    death   

Project "PROTECTA" data sheet

The following table provides information about the project.

Coordinator
SVERIGES LANTBRUKSUNIVERSITET 

Organization address
address: ALMAS ALLE 8
city: UPPSALA
postcode: 750 07
website: http://www.slu.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 3˙992˙284 €
 EC max contribution 3˙992˙284 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2022-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SVERIGES LANTBRUKSUNIVERSITET SE (UPPSALA) coordinator 1˙054˙637.00
2    THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN UK (ABERDEEN) participant 819˙863.00
3    UNIVERSITE PAUL SABATIER TOULOUSE III FR (TOULOUSE CEDEX 9) participant 525˙751.00
4    NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET NO (AS) participant 286˙275.00
5    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 273˙287.00
6    MARIBOHILLESHOG RESEARCH AB SE (LANDSKRONA) participant 263˙659.00
7    UNIVERSITA DEGLI STUDI DELLA TUSCIA IT (VITERBO) participant 258˙061.00
8    ONTWIKKELINGSMAATSCHAPPIJ HET IDEE NL (ROTTERDAM) participant 255˙374.00
9    WAGENINGEN UNIVERSITY NL (WAGENINGEN) participant 255˙374.00

Map

 Project objective

The oomycetes are a distinct lineage of Eukaryotic microbes that resemble fungi, but are genetically related to the heterokont (brown) algae. Oomycetes have a worldwide distribution and are destructive and highly adaptable pathogens, infecting vascular plants, fish, insects fungi and occasionally humans. Notorious crop damaging pathogens such as the potato late blight pathogen Phytophthora infestans, vegetable root rots and (re)-emerging diseases such as fish saprolegniosis and Sudden Oak Death are global threats to food security and natural ecosystems. Comparative genomics in the oomycetes reveals major classes of effector proteins used by pathogens to manipulate hosts that can also be recognised by host immune systems. The major challenges in oomycete research are to identify the precise biochemical functions of major pathogenicity determinants (such as effector proteins) and host immune responses (such as plant resistance genes) and translate this research into durable disease control in agriculture, ecosystems and aquaculture. We have assembled a multidisciplinary, inter-sectoral team including some of Europe’s leading researchers in the field, SMEs, multinational companies and government agencies, to train the next generation of European researchers to address these challenges. PROTECTA aims for a large-scale quantification of effector gene expression and protein abundance during the infection process of oomycetes that infect diverse crop, tree, and fish hosts. We will advance our fundamental understanding of the genetics and biochemistry of host-oomycete interactions on an unprecedented scale. We will exploit this data to identify new mechanisms of host resistance and work directly with plant breeding and aquaculture companies to translate our results into new crop varieties with durable resistance, new ways to protect fish in aquaculture, and new biological control methods to protect agricultural systems and reduce European dependence on chemical pesticides.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PROTECTA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PROTECTA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

GREAT (2019)

Grating Reflectors Enabled laser Applications and Training

Read More  

LIVE-I (2020)

Lightening and Innovating transmission for improving Vehicle: Environmental Impacts

Read More  

LongActNow (2019)

Long Acting Medicines for Complex Therapeutics Needed Now

Read More